The Efficacy of Diphenylcyclopropenone in Treatment of Molluscum Contagiosum
Ibrahim, S., Fathy, M., Abd Elmoniem, N., Ebrahim, H. (2023). The Efficacy of Diphenylcyclopropenone in Treatment of Molluscum Contagiosum. EKB Journal Management System, 29(1.1), 151-158. doi: 10.21608/zumj.2020.34318.1890
Samia Ali Ibrahim; Marwa Mohamed Fathy; Nesma Elsayed Abd Elmoniem; Howyda Mohamed Ebrahim. "The Efficacy of Diphenylcyclopropenone in Treatment of Molluscum Contagiosum". EKB Journal Management System, 29, 1.1, 2023, 151-158. doi: 10.21608/zumj.2020.34318.1890
Ibrahim, S., Fathy, M., Abd Elmoniem, N., Ebrahim, H. (2023). 'The Efficacy of Diphenylcyclopropenone in Treatment of Molluscum Contagiosum', EKB Journal Management System, 29(1.1), pp. 151-158. doi: 10.21608/zumj.2020.34318.1890
Ibrahim, S., Fathy, M., Abd Elmoniem, N., Ebrahim, H. The Efficacy of Diphenylcyclopropenone in Treatment of Molluscum Contagiosum. EKB Journal Management System, 2023; 29(1.1): 151-158. doi: 10.21608/zumj.2020.34318.1890

The Efficacy of Diphenylcyclopropenone in Treatment of Molluscum Contagiosum

Zagazig University Medical Journal
Article 22, Volume 29, Issue 1.1, January 2023, Page 151-158  XML PDF (411.11 K)
Document Type: Original Article
DOI: 10.21608/zumj.2020.34318.1890
View on SCiNiTO View on SCiNiTO
Authors
Samia Ali Ibrahim1; Marwa Mohamed Fathy2; Nesma Elsayed Abd Elmoniem email 3; Howyda Mohamed Ebrahim4
1Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2Department of Dermatology, Venereology and Andrology,Faculty of Medicine, Zagazig University, Zagazig, Egypt,
3Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig,Egypt,
4Zagazig University Hospital
Abstract
Abstract
Background
Diphenylcyclopropenone (DPCP) contact immunotherapy has been successfully utilized in various forms for treatments of recalcitrant and facial warts, molluscum contagiosum (MC) and alopecia areata.
Objective
The objective was to evaluate the safety and efficacy of DPCP in the treatment of MC.
Patients and Methods
Twenty-four patients with MC were assigned to two groups: twelve patients (group A) were treated with topical application of DPCP one session per week for a maximum of 12 sessions or until clinical cure. Also, twelve patients (group B) were subjected to topical application of normal neutral saline as a control group. Follow-up was done for 3 months.
Results
In group A, eight patients (66.7%) showed complete response while four patients (33.3%) showed partial response to the topical application of DPCP after seven to twelve sessions. However, in group B, eleven patients (91.7%) showed no response and (8.3%) showed partial response. A highly significant difference was found in the clinical response between both groups (p < /p>
Keywords
Molluscumcontagiosum; Diphenylcyclopropenone; immunotherapy
Statistics
Article View: 462
PDF Download: 157